Medical Research News and Research

RSS

Translational Medicine Graduate Training Program awarded $700,000 HHMI grant

The Graduate Training Program in Translational Medicine at the University of North Carolina at Chapel Hill has been awarded a four-year, $700,000 "Med into Grad" renewal grant from the Howard Hughes Medical Institute.

1 Dec 2009

NRR to be available exclusively on OvidSP online search and discovery platform to all Ovid customers

As part of ongoing efforts to strengthen its presence in China's healthcare information market, Ovid, a part of Wolters Kluwer Health and a global leader in electronic scientific, medical, and academic information research solutions, is pleased to announce an agreement with Neural Regeneration Research (NRR), an English-language monthly journal dedicated to presenting peer-reviewed, evidence-based scholarly research in stem cells and regeneration.

1 Dec 2009

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.

1 Dec 2009

Low-dose radiation increases breast cancer risk in high-risk women

Low-dose radiation from annual mammography screening may increase breast cancer risk in women with genetic or familial predisposition to breast cancer, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

Xybion completes the acquisition of all operating assets of Amadeus Solutions

Xybion Corporation announced today that through the creation of a wholly owned Quebec Corporation, Services Informatiques Xybion, it has completed the acquisition of all operating assets of Quebec City based Amadeus Solutions, a leader in the development of enterprise governance, risk, compliance and quality management software solutions, from DECIMAL, a corporate performance management organization headquartered in Montreal.

1 Dec 2009

Reductionist model provides new insights on HIV infection

A major obstacle to HIV research is the virus's exquisite specialisation for its human host - meaning that scientists' traditional tools, like the humble lab mouse, can deliver only limited information. Now, a team of researchers writing in BioMed Central's open access Journal of Biology have made an ingenious assault on this problem by creating a mouse that has key features of HIV infection without being infected with HIV.

1 Dec 2009

Clinical trials of personalised vaccines to fight glioblastomas

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced from healthy and tumour cells from the patient him or herself— and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.

30 Nov 2009

Scientists demonstrate stem cells heal lungs of newborn rats; study anticipated to benefit premature babies

Dr. Bernard Th-baud lives in two very different worlds. As a specialist in the Stollery Children's Hospital's Neonatal Intensive Care Unit at the Royal Alexandra Hospital, he cares for tiny babies, many of whom struggle for breath after being born weeks before they are due.

27 Nov 2009

IES to install electrical systems at the U.S. Army Medical Research Institute of Infectious Diseases

IES, a leading national provider of electrical and communications systems and services for the commercial, industrial and residential markets, announced today that its commercial business group has been awarded a contract from Manhattan Torcon JV to install the electrical systems for the Level 4 bio-safety lab (BSL-4) replacement facility at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md.

25 Nov 2009

CXCL5 molecule causes insulin resistance and type 2 diabetes in obese people

Many people who are overweight or obese develop insulin resistance and type 2 diabetes at some stage in their lives. A European research team has now discovered that obese people have large amounts of the molecule CXCL5, produced by certain cells in fatty tissue.

25 Nov 2009

LRI awards $3.6 million grants to drive innovative science in lupus and related diseases

The Lupus Research Institute (LRI) today named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus.

24 Nov 2009

JDRF partners with the Canadian Government in diabetes research

Juvenile Diabetes Research Foundation (JDRF) Canada is pleased to announce its first partnership with the Government of Canada through the Federal Economic Development Agency of Southern Ontario. Through this innovative two-year partnership, the Government of Canada is committing $20 million and JDRF is making a matching contribution of $10 million to accelerate world-class diabetes research in Southern Ontario by implementing a clinical trial network for diabetes research.

23 Nov 2009

Alcohol consumption in pregnancy affects child behaviour in different ways: Study

A new study from Perth's Telethon Institute for Child Health Research has found evidence that the amount and timing of alcohol consumption in pregnancy affects child behaviour in different ways.

23 Nov 2009

Six outstanding contributors to health and medical research industry recognised

Six outstanding contributors to the health and medical research industry are being recognised by Research Australia in its annual "Thank You" Day awards tomorrow (Friday 20 November 2009).

20 Nov 2009

NIEHS grants $13 million for engineered nanomaterials research

The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is increasing its investment in understanding the potential health, safety and environmental issues related to tiny particles that are used in many everyday products such as sunscreens, cosmetics and electronics. The NIEHS will award about $13 million over a two-year period, through the American Recovery and Reinvestment Act, to bolster the NIEHS's ongoing research portfolio in the area of engineered nanomaterials (ENMs).

20 Nov 2009

University of Leeds scientists' discovery could lead to new treatment route for BSE and CJD

A new treatment route for bovine spongiform encephalopathy (BSE) and its human form Creutzfeldt Jakob disease (CJD) could be a step closer thanks to a discovery by scientists at the University of Leeds.

20 Nov 2009

New technology to investigate sleep disorders developed

Virtanen has developed a method for analysing snoring sounds by using a PC with a microphone connection and a wireless microphone. The objective was to create an application that could be used at home to monitor snoring. By utilizing this technology, researchers from Tampere University of Technology and the University of Helsinki have investigated sleep disorders and further refined related screening technologies.

19 Nov 2009

BIMR wins a GO grant from the National Institute of Mental Health

Thanks to a $50,000 grant from the California Bipolar Foundation (CBF) to post-doctoral research fellow Dr. Illyas Singec at the Burnham Institute for Medical Research (BIMR), a research team headed by Dr. Evan Snyder (along with co-investigators Drs. Dieter Wolfe and Lawrence Brill), was able to accumulate sufficient preliminary data to win an extremely competitive Grand Opportunities (GO) grant from the National Institute of Mental Health to explore the molecular basis of Bipolar Disorder (BPD).

19 Nov 2009

New mathematical model may hasten drug development for Parkinson's Disease

Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's Disease.

19 Nov 2009

Review of the results of Phase 2b clinical trial on PASCAL announced

ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx’s compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.

18 Nov 2009

Medical Research News and Research

Translational Medicine Graduate Training Program awarded $700,000 HHMI grant

NRR to be available exclusively on OvidSP online search and discovery platform to all Ovid customers

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

Low-dose radiation increases breast cancer risk in high-risk women

Xybion completes the acquisition of all operating assets of Amadeus Solutions

Reductionist model provides new insights on HIV infection

Clinical trials of personalised vaccines to fight glioblastomas

Scientists demonstrate stem cells heal lungs of newborn rats; study anticipated to benefit premature babies

IES to install electrical systems at the U.S. Army Medical Research Institute of Infectious Diseases

CXCL5 molecule causes insulin resistance and type 2 diabetes in obese people

LRI awards $3.6 million grants to drive innovative science in lupus and related diseases

JDRF partners with the Canadian Government in diabetes research

Alcohol consumption in pregnancy affects child behaviour in different ways: Study

Six outstanding contributors to health and medical research industry recognised

NIEHS grants $13 million for engineered nanomaterials research

University of Leeds scientists' discovery could lead to new treatment route for BSE and CJD

New technology to investigate sleep disorders developed

BIMR wins a GO grant from the National Institute of Mental Health

New mathematical model may hasten drug development for Parkinson's Disease

Review of the results of Phase 2b clinical trial on PASCAL announced

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News